Growth factor mutants with improved biological activity

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention discloses novel engineered mutants of growth factors, specifically from the GDF-5, GDF-6, and GDF-7 family, which have been biosynthetically altered to possess significantly enhanced biological activity compared to their natural forms. By substituting certain amino acids at crucial positions in these proteins, the resulting mutants demonstrate improved efficacy in promoting cell growth, differentiation, and tissue regeneration. The patent also covers the genetic sequences, production methods, and possible pharmaceutical formulations for these enhanced growth factors, as well as their diagnostic and therapeutic applications.

Use CasesContent extracted from patent full text and abstract with AI.

• Regenerative medicine for repairing or regenerating bone, cartilage, tendon, ligament, spinal discs, and periodontal tissues.
• Treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's, via promotion of nerve growth and survival.
• Accelerating wound healing in skin, including for burns, ulcers, or surgical sites.
• Enhancing repair or regeneration after dental procedures, such as promoting periodontal ligament or dentin regrowth.
• Supporting tissue and organ transplantation by improving cell differentiation and proliferation.
• Stimulating angiogenesis for restoration of blood vessels in ischemic or damaged tissues.
• Promoting hair growth and treating certain skin disorders.
• Cosmetic applications for improved healing, reduced scarring, or stimulating skin cell renewal.

BenefitsContent extracted from patent full text and abstract with AI.

• Increased biological activity compared to natural growth factors, allowing lower doses or greater therapeutic effect.
• Broader range of tissue-specific regenerative potential including bone, cartilage, neural, dental, and skin tissues.
• Improved outcomes in tissue engineering, wound healing, and cell therapy applications.
• Potentially faster or more complete tissue repair and regeneration.
• Enables development of new pharmaceuticals and therapeutic proteins for degenerative diseases.
• Customizable through further genetic engineering for various medical and research needs.
• Compatibility with existing biomaterial matrices or slow-release delivery systems for sustained therapeutic effects.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The invention relates to novel biosynthetic growth factor mutants which exhibit improved biological activity.